Compare TMCI & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMCI | AXR |
|---|---|---|
| Founded | 2014 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 132.0M |
| IPO Year | 2021 | 2010 |
| Metric | TMCI | AXR |
|---|---|---|
| Price | $3.91 | $24.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.77 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.2M | 4.8K |
| Earning Date | 05-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.60 |
| EPS | N/A | ★ 1.68 |
| Revenue | ★ $212,690,000.00 | $12,831,000.00 |
| Revenue This Year | N/A | $10.12 |
| Revenue Next Year | $8.18 | N/A |
| P/E Ratio | ★ N/A | $15.20 |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.17 | $17.61 |
| 52 Week High | $7.78 | $29.01 |
| Indicator | TMCI | AXR |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 48.63 |
| Support Level | $2.46 | $24.31 |
| Resistance Level | $4.47 | $25.89 |
| Average True Range (ATR) | 0.45 | 0.76 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 16.67 | 37.19 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.